The DOI matches its Crossref record; 250 of the 250 references it cites were found in a registry or an index.
Copper Dyshomeostasis in Neurodegenerative Diseases—Therapeutic Implications
Open accessAbstract
Copper is one of the most abundant basic transition metals in the human body. It takes part in oxygen metabolism, collagen synthesis, and skin pigmentation, maintaining the integrity of blood vessels, as well as in iron homeostasis, antioxidant defense, and neurotransmitter synthesis. It may also be involved in cell signaling and may participate in modulation of membrane receptor-ligand interactions, control of kinase and related phosphatase functions, as well as many cellular pathways. Its role is also important in controlling gene expression in the nucleus. In the nervous system in particular, copper is involved in myelination, and by modulating synaptic activity as well as excitotoxic cell death and signaling cascades induced by neurotrophic factors, copper is important for various neuronal functions. Current data suggest that both excess copper levels and copper deficiency can be harmful, and careful homeostatic control is important. This knowledge opens up an important new area for potential therapeutic interventions based on copper supplementation or removal in neurodegenerative diseases including Wilson’s disease (WD), Menkes disease (MD), Alzheimer’s disease (AD), Parkinson’s disease (PD), and others. However, much remains to be discovered, in particular, how to regulate copper homeostasis to prevent neurodegeneration, when to chelate copper, and when to supplement it.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
Bhattacharyya, A., Chattopadhyay, R., Mitra, S., & Crowe, S. E. (2014) · Physiological Reviews · doi:10.1152/physrev.00040.2012 · Cited by 2,484
Neurotrophins and their receptors: A convergence point for many signalling pathways
Chao, M. V. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1078 · Cited by 2,298
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
Cheignon, C., Tomas, M., Bonnefont-Rousselot, D., Faller, P., Hureau, C., & Collin, F. (2018) · Redox Biology · doi:10.1016/j.redox.2017.10.014 · Cited by 2,185
Kurutas, E. B. (2015) · Nutrition Journal · doi:10.1186/s12937-016-0186-5 · Cited by 2,152
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
Metals in Neurobiology: Probing Their Chemistry and Biology with Molecular Imaging
Que, E. L., Domaille, D. W., & Chang, C. J. (2008) · Chemical Reviews · doi:10.1021/cr078203u · Cited by 2,061
Superoxide Dismutases: Role in Redox Signaling, Vascular Function, and Diseases
Fukai, T., & Ushio-Fukai, M. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3999 · Cited by 1,983
The Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
van der Put, N. M. J., Gabreëls, F., Stevens, E. M. B., Smeitink, J. A. M., Trijbels, F. J. M., Eskes, T. K. A. B., van den Heuvel, L. P., & Blom, H. J. (1998) · The American Journal of Human Genetics · doi:10.1086/301825 · Cited by 1,556
Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447
-Synuclein in Parkinson's Disease
Stefanis, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009399 · Cited by 1,446
Ala, A., Walker, A. P., Ashkan, K., Dooley, J. S., & Schilsky, M. L. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60196-2 · Cited by 1,446
Heavy metals and living systems: An overview
Singh, R., Gautam, N., Mishra, A., & Gupta, R. (2011) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.81505 · Cited by 1,390
Oxidative Stress in Neurodegenerative Diseases
Simonian, N. A., & Coyle, J. T. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.000503 · Cited by 1,377
Astrocyte barriers to neurotoxic inflammation
Sofroniew, M. V. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3898 · Cited by 1,202
Evolution of Liver Transplantation
Starzl, T. E., Iwatsuki, S., Van Thiel, D. H., Gartner, C. J., Zitelli, B. J., Malatack, J. J., Schade, R. R., Shaw, B. W., Hakala, T. R., Rosenthal, T. J., et al. (1982) · Hepatology · doi:10.1002/hep.1840020516 · Cited by 871
Oxidative Stress and the Pathogenesis of Alzheimer's Disease
Zhao, Y., & Zhao, B. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/316523 · Cited by 855
The Role of Metallothionein in Oxidative Stress
Ruttkay-Nedecky, B., Nejdl, L., Gumulec, J., Zitka, O., Masarik, M., Eckschlager, T., Stiborova, M., Adam, V., & Kizek, R. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14036044 · Cited by 839
Chemistry and biology of eukaryotic iron metabolism
Aisen, P. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00063-2 · Cited by 804
Copper in diseases and treatments, and copper‐based anticancer strategies
Tisato, F., Marzano, C., Porchia, M., Pellei, M., & Santini, C. (2010) · Medicinal Research Reviews · doi:10.1002/med.20174 · Cited by 797
Physiology of Intestinal Absorption and Secretion
Kiela, P. R., & Ghishan, F. K. (2016) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.02.007 · Cited by 752 · cited 1×
“In this form, this element is distributed with blood throughout the body [22,44].”
BackgroundCopper: toxicological relevance and mechanisms
Gaetke, L. M., Chow-Johnson, H. S., & Chow, C. K. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1355-y · Cited by 743
Bush, A. (2000) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)00073-3 · Cited by 731
Lannfelt, L., Blennow, K., Zetterberg, H., Batsman, S., Ames, D., Harrison, J., Masters, C. L., Targum, S., Bush, A. I., Murdoch, R., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70167-4 · Cited by 725
Penicillamine, a new oral therapy for Wilson's disease
Walshe, J. M. (1956) · The American Journal of Medicine · doi:10.1016/0002-9343(56)90066-3 · Cited by 707
The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum.
Osaki, S., Johnson, D. A., & Frieden, E. (1966) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)96527-0 · Cited by 679
Adlard, P. A., Cherny, R. A., Finkelstein, D. I., Gautier, E., Robb, E., Cortes, M., Volitakis, I., Liu, X., Smith, J. P., Perez, K., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.018 · Cited by 672
ATP7A-related copper transport diseases—emerging concepts and future trends
Kaler, S. G. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.180 · Cited by 630
Copper and Zinc, Biological Role and Significance of Copper/Zinc Imbalance
Osredkar, J. (2011) · Journal of Clinical Toxicology · doi:10.4172/2161-0495.s3-001 · Cited by 620
The Role of Hepcidin in Iron Metabolism
Nemeth, E., & Ganz, T. (2009) · Acta Haematologica · doi:10.1159/000243791 · Cited by 607
A review on role of essential trace elements in health and disease
Prashanth, L., Kattapagari, K. K., Chitturi, R. T., Baddam, V. R. R., & Prasad, L. K. (2015) · Journal of Dr. NTR University of Health Sciences · doi:10.4103/2277-8632.158577 · Cited by 604
The Role of NMDA Receptors in Alzheimer’s Disease
Liu, J., Chang, L., Song, Y., Li, H., & Wu, Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00043 · Cited by 535
An improved colorimetric enzymatic assay of ceruloplasmin.
Ravin, H. A. (1961) · PubMed · Cited by 531
Taylor, A. A., Tsuji, J. S., Garry, M. R., McArdle, M. E., Goodfellow, W. L., Adams, W. J., & Menzie, C. A. (2020) · Environmental Management · doi:10.1007/s00267-019-01234-y · Cited by 512
Biological metals and metal-targeting compounds in major neurodegenerative diseases
Barnham, K. J., & Bush, A. I. (2014) · Chem. Soc. Rev. · doi:10.1039/c4cs00138a · Cited by 497
Trafficking of the copper-ATPases, ATP7A and ATP7B: Role in copper homeostasis
La Fontaine, S., & Mercer, J. F. B. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.04.021 · Cited by 467
Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide
Lang, P. A., Schenck, M., Nicolay, J. P., Becker, J. U., Kempe, D. S., Lupescu, A., Koka, S., Eisele, K., Klarl, B. A., Rübben, H., et al. (2007) · Nature Medicine · doi:10.1038/nm1539 · Cited by 438
Glutathione metabolism and Parkinson's disease
Smeyne, M., & Smeyne, R. J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.001 · Cited by 435
Rasia, R. M., Bertoncini, C. W., Marsh, D., Hoyer, W., Cherny, D., Zweckstetter, M., Griesinger, C., Jovin, T. M., & Fernández, C. O. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407881102 · Cited by 408
PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses
Faux, N. G., Ritchie, C. W., Gunn, A., Rembach, A., Tsatsanis, A., Bedo, J., Harrison, J., Lannfelt, L., Blennow, K., Zetterberg, H., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1390 · Cited by 405
Copper Binding in the Prion Protein
Millhauser, G. L. (2004) · Accounts of Chemical Research · doi:10.1021/ar0301678 · Cited by 392
Tümer, Z., & Møller, L. B. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.187 · Cited by 388
Astrocyte Heterogeneity: Impact to Brain Aging and Disease
Matias, I., Morgado, J., & Gomes, F. C. A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00059 · Cited by 387
Dooley, J. S., & Ala, A. (2010) · Evidence‐Based Gastroenterology and Hepatology · doi:10.1002/9781444314403.ch31 · Cited by 386
Alpha-synuclein biology in Lewy body diseases
Kim, W. S., Kågedal, K., & Halliday, G. M. (2014) · Alzheimer's Research & Therapy · doi:10.1186/s13195-014-0073-2 · Cited by 374
Oxidative Stress in Neurodegenerative Diseases
(2013) · Metal‐based Neurodegeneration · doi:10.1002/9781118553480.ch04 · Cited by 371
Glutamine synthetase in brain: effect of ammonia
Suárez, I., Bodega, G., & Fernández, B. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(02)00033-5 · Cited by 365
Deas, E., Cremades, N., Angelova, P. R., Ludtmann, M. H. R., Yao, Z., Chen, S., Horrocks, M. H., Banushi, B., Little, D., Devine, M. J., et al. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6343 · Cited by 360
Metabolic crossroads of iron and copper
Collins, J. F., Prohaska, J. R., & Knutson, M. D. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00271.x · Cited by 356
Oxidative stress in neurodegenerative diseases.
Chen, X., Guo, C., & Kong, J. (2012) · PubMed · doi:10.3969/j.issn.1673-5374.2012.05.009 · Cited by 356
Metals and amyloid‐β in Alzheimer's disease
Maynard, C. J., Bush, A. I., Masters, C. L., Cappai, R., & Li, Q. (2005) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2005.00434.x · Cited by 353
The cuprizone model for demyelination
Torkildsen, Ø., Brunborg, L. A., Myhr, K.-M., & Bø, L. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01036.x · Cited by 346
Copper Transporters and the Cellular Pharmacology of the Platinum-Containing Cancer Drugs
Howell, S. B., Safaei, R., Larson, C. A., & Sailor, M. J. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.063172 · Cited by 344
Brewer, G. J., Terry, C. A., Aisen, A. M., & Hill, G. M. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520170020016 · Cited by 335
Glial cells in neuronal network function
Araque, A., & Navarrete, M. (2010) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2009.0313 · Cited by 324
Biophysics of Parkinsons Disease: Structure and Aggregation of α- Synuclein
Uversky, V., & Eliezer, D. (2009) · Current Protein & Peptide Science · doi:10.2174/138920309789351921 · Cited by 322
Radical changes in multiple sclerosis pathogenesis
van Horssen, J., Witte, M. E., Schreibelt, G., & de Vries, H. E. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.06.011 · Cited by 322
Brewer, G. J., Askari, F., Lorincz, M. T., Carlson, M., Schilsky, M., Kluin, K. J., Hedera, P., Moretti, P., Fink, J. K., Tankanow, R., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.4.521 · Cited by 322
Lloyd, D. R., & Phillips, D. H. (1999) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(99)00005-6 · Cited by 309
Ceruloplasmin and other copper binding components of blood plasma and their functions: an update
Linder, M. C. (2016) · Metallomics · doi:10.1039/c6mt00103c · Cited by 308
Zheng, W., & Monnot, A. D. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.10.006 · Cited by 302
Resolution of inflammation is altered in Alzheimer's disease
Wang, X., Zhu, M., Hjorth, E., Cortés‐Toro, V., Eyjolfsdottir, H., Graff, C., Nennesmo, I., Palmblad, J., Eriksdotter, M., Sambamurti, K., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.12.024 · Cited by 301
Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases
Danielsen, E. R. (1999) · CRC Press eBooks · doi:10.1201/9781482270105 · Cited by 301
The many “faces” of copper in medicine and treatment
Hordyjewska, A., Popiołek, Ł., & Kocot, J. (2014) · BioMetals · doi:10.1007/s10534-014-9736-5 · Cited by 298
Copper and Zinc Dysregulation in Alzheimer’s Disease
Sensi, S. L., Granzotto, A., Siotto, M., & Squitti, R. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.10.001 · Cited by 285
Iron and Alzheimer’s Disease: From Pathogenesis to Therapeutic Implications
Liu, J.-L., Fan, Y.-G., Yang, Z.-S., Wang, Z.-Y., & Guo, C. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00632 · Cited by 284
DMT1, a physiologically relevant apical Cu1+transporter of intestinal cells
Arredondo, M., Muñoz, P., Mura, C. V., & Núñez, M. T. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00480.2002 · Cited by 279
Allaman, I., Gavillet, M., Bélanger, M., Laroche, T., Viertl, D., Lashuel, H. A., & Magistretti, P. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5098-09.2010 · Cited by 278
Human Copper Transporters: Mechanism, Role in Human Diseases and Therapeutic Potential
Gupta, A., & Lutsenko, S. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.84 · Cited by 275
Monzani, E., Nicolis, S., Dell'Acqua, S., Capucciati, A., Bacchella, C., Zucca, F. A., Mosharov, E. V., Sulzer, D., Zecca, L., & Casella, L. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201811122 · Cited by 271
Drug Development Based on the Metals Hypothesis of Alzheimer's Disease
Bush, A. I. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-15208 · Cited by 267
Initiation and propagation of α-synuclein aggregation in the nervous system
Hijaz, B. A., & Volpicelli-Daley, L. A. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00368-6 · Cited by 262
White, A. R., Huang, X., Jobling, M. F., Barrow, C. J., Beyreuther, K., Masters, C. L., Bush, A. I., & Cappai, R. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00178.x · Cited by 260
Garza-Lombó, C., Posadas, Y., Quintanar, L., Gonsebatt, M. E., & Franco, R. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7272 · Cited by 252
Glutamate Receptors as Therapeutic Targets for Parkinsons Disease
Johnson, K., Conn, P., & Niswender, C. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824606 · Cited by 251
Copper transport to the brain by the blood-brain barrier and blood-CSF barrier
Choi, B.-S., & Zheng, W. (2009) · Brain Research · doi:10.1016/j.brainres.2008.10.056 · Cited by 250
Copper pathology in vulnerable brain regions in Parkinson's disease
Davies, K. M., Bohic, S., Carmona, A., Ortega, R., Cottam, V., Hare, D. J., Finberg, J. P. M., Reyes, S., Halliday, G. M., Mercer, J. F. B., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.034 · Cited by 244
The transition metals copper and iron in neurodegenerative diseases
Rivera-Mancía, S., Pérez-Neri, I., Ríos, C., Tristán-López, L., Rivera-Espinosa, L., & Montes, S. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.04.010 · Cited by 244
Characterization of Mouse Embryonic Cells Deficient in the Ctr1 High Affinity Copper Transporter
Lee, J., Petris, M. J., & Thiele, D. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208002200 · Cited by 244
Copper Ions and Parkinson’s Disease: Why Is Homeostasis So Relevant?
Bisaglia, M., & Bubacco, L. (2020) · Biomolecules · doi:10.3390/biom10020195 · Cited by 226
Intestinal Absorption and Factors Influencing Bioavailability of Magnesium- An Update
Schuchardt, J. P., & Hahn, A. (2017) · Current Nutrition & Food Science · doi:10.2174/1573401313666170427162740 · Cited by 225
Schiweck, J., Eickholt, B. J., & Murk, K. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00261 · Cited by 223
White, A. R., Multhaup, G., Maher, F., Bellingham, S., Camakaris, J., Zheng, H., Bush, A. I., Beyreuther, K., Masters, C. L., & Cappai, R. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-21-09170.1999 · Cited by 222
Oxidant/Antioxidant Imbalance in Alzheimer’s Disease: Therapeutic and Diagnostic Prospects
Wojsiat, J., Zoltowska, K. M., Laskowska-Kaszub, K., & Wojda, U. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6435861 · Cited by 221
Role of Copper in the Onset of Alzheimer’s Disease Compared to Other Metals
Bagheri, S., Squitti, R., Haertlé, T., Siotto, M., & Saboury, A. A. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00446 · Cited by 221
Dodani, S. C., Domaille, D. W., Nam, C. I., Miller, E. W., Finney, L. A., Vogt, S., & Chang, C. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009932108 · Cited by 217
How Mammalian Cells Acquire Copper: An Essential but Potentially Toxic Metal
Kaplan, J. H., & Maryon, E. B. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2015.11.025 · Cited by 216
Copper signalling: causes and consequences
Kardos, J., Héja, L., Simon, Á., Jablonkai, I., Kovács, R., & Jemnitz, K. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0277-3 · Cited by 213
Copper signaling in the mammalian nervous system: Synaptic effects
Gaier, E. D., Eipper, B. A., & Mains, R. E. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23143 · Cited by 209
Multi-Copper Oxidases and Human Iron Metabolism
Vashchenko, G., & MacGillivray, R. (2013) · Nutrients · doi:10.3390/nu5072289 · Cited by 208
Copper and Copper Proteins in Parkinson’s Disease
Montes, S., Rivera-Mancia, S., Diaz-Ruiz, A., Tristan-Lopez, L., & Rios, C. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/147251 · Cited by 203
Copper as a key regulator of cell signalling pathways
Grubman, A., & White, A. R. (2014) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2014.11 · Cited by 196
Searching for harmony in transition-metal signaling
Chang, C. J. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1913 · Cited by 193
Inherited Copper Transport Disorders: Biochemical Mechanisms, Diagnosis, and Treatment
Kodama, H., Fujisawa, C., & Bhadhprasit, W. (2012) · Current Drug Metabolism · doi:10.2174/138920012799320455 · Cited by 191
Initial Therapy of Patients With Wilson's Disease With Tetrathiomolybdate
Brewer, G. J., Dick, R. D., Yuzbasiyan-Gurkin, V., Tankanow, R., Young, A. B., & Kluin, K. J. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530130050019 · Cited by 190
Copper transporters and copper chaperones: roles in cardiovascular physiology and disease
Fukai, T., Ushio-Fukai, M., & Kaplan, J. H. (2018) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00132.2018 · Cited by 189
Copper at synapse: Release, binding and modulation of neurotransmission
D'Ambrosi, N., & Rossi, L. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.07.006 · Cited by 188
Gomes, F. C. A., Paulin, D., & Moura Neto, V. (1999) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1999000500016 · Cited by 188
Lipid Metabolism Crosstalk in the Brain: Glia and Neurons
Barber, C. N., & Raben, D. M. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00212 · Cited by 188
Singh, S. K., Srivastav, S., Yadav, A. K., Srikrishna, S., & Perry, G. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/7361613 · Cited by 186
Metal Ion Effects on Aβ and Tau Aggregation
Kim, A. C., Lim, S., & Kim, Y. K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010128 · Cited by 186
Heldin, C., Lu, B. C., Evans, R. M., & Gutkind, J. S. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005900 · Cited by 184
Hatori, Y., & Lutsenko, S. (2016) · Antioxidants · doi:10.3390/antiox5030025 · Cited by 182
Nose, Y., Wood, L. K., Kim, B., Prohaska, J. R., Fry, R. S., Spears, J. W., & Thiele, D. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.143826 · Cited by 181
Hottinger, A. F., Fine, E. G., Gurney, M. E., Zurn, A. D., & Aebischer, P. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01511.x · Cited by 180
Duodenal Cytochrome b (DCYTB) in Iron Metabolism: An Update on Function and Regulation
Lane, D. J. R., Bae, D.-H., Merlot, A. M., Sahni, S., & Richardson, D. R. (2015) · Nutrients · doi:10.3390/nu7042274 · Cited by 177
Role of the P-Type ATPases, ATP7A and ATP7B in brain copper homeostasis
Telianidis, J., Hung, Y. H., Materia, S., & Fontaine, S. L. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00044 · Cited by 176
Copper Transport in Mammalian Cells: Special Care for a Metal with Special Needs
Kaplan, J. H., & Lutsenko, S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.031286 · Cited by 171
The genetics of Wilson disease
Chang, I. J., & Hahn, S. H. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63625-6.00003-3 · Cited by 168
Primary Cultures of Astrocytes: Their Value in Understanding Astrocytes in Health and Disease
Lange, S. C., Bak, L. K., Waagepetersen, H. S., Schousboe, A., & Norenberg, M. D. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0868-0 · Cited by 167
Challenges Associated with Metal Chelation Therapy in Alzheimer's Disease
Hegde, M. L., Bharathi, P., Suram, A., Venugopal, C., Jagannathan, R., Poddar, P., Srinivas, P., Sambamurti, K., Rao, K. J., Scancar, J., et al. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1068 · Cited by 167
Skjørringe, T., Burkhart, A., Johnsen, K. B., & Moos, T. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00019 · Cited by 166
Forbes, J. R., Hsi, G., & Cox, D. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12408 · Cited by 166
DiDonato, M., Narindrasorasak, S., Forbes, J. R., Cox, D. W., & Sarkar, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.52.33279 · Cited by 166
Mechanisms of Endogenous Neuroprotective Effects of Astrocytes in Brain Injury
Bylicky, M. A., Mueller, G. P., & Day, R. M. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6501031 · Cited by 165
Myhre, O., Utkilen, H., Duale, N., Brunborg, G., & Hofer, T. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/726954 · Cited by 164
de Bie, P., van de Sluis, B., Burstein, E., van de Berghe, P. V. E., Muller, P., Berger, R., Gitlin, J. D., Wijmenga, C., & Klomp, L. W. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.07.020 · Cited by 163
Williams, J. R., Trias, E., Beilby, P. R., Lopez, N. I., Labut, E. M., Bradford, C. S., Roberts, B. R., McAllum, E. J., Crouch, P. J., Rhoads, T. W., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.01.020 · Cited by 163
Proton Magnetic Resonance Spectroscopy for the Diagnosis and Management of Cerebral Disorders
Rudkin, T. M., & Arnold, D. L. (1999) · Archives of Neurology · doi:10.1001/archneur.56.8.919 · Cited by 160
Glial connexins and gap junctions in CNS inflammation and disease
Kielian, T. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05405.x · Cited by 159
Effect of metal ions on the rearrangement of dopachrome
PALUMBO, A., DISCHIA, M., MISURACA, G., & PROTA, G. (1987) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(87)90110-3 · Cited by 158
van der Hart, M. G. C., Czéh, B., de Biurrun, G., Michaelis, T., Watanabe, T., Natt, O., Frahm, J., & Fuchs, E. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001130 · Cited by 158
Schlief, M. L., & Gitlin, J. D. (2006) · Molecular Neurobiology · doi:10.1385/mn:33:2:81 · Cited by 157
Mechanism of Copper Uptake from Blood Plasma Ceruloplasmin by Mammalian Cells
Ramos, D., Mar, D., Ishida, M., Vargas, R. E., Gaite, M., Montgomery, A. P., & Linder, M. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149516 · Cited by 156
Copper Toxicity Links to Pathogenesis of Alzheimer’s Disease and Therapeutics Approaches
Ijaz, H. W., Wang, W., & Lang, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207660 · Cited by 152
Kim, T. J., Kim, I. O., Kim, W. S., Cheon, J., Moon, S.-Y., Kwon, J. W., Seo, J. K., & Yeon, K. M. (2006) · PubMed · Cited by 151
Astrocyte functions in the copper homeostasis of the brain
Scheiber, I. F., & Dringen, R. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.08.017 · Cited by 151
Rahil-Khazen, R., Bolann, B. J., Myking, A. O., & Ulvik, R. J. (2002) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/s0946-672x(02)80004-9 · Cited by 151
James, S., Churches, Q. I., de Jonge, M. D., Birchall, I. E., Streltsov, V. A., McColl, G., Adlard, P. A., & Hare, D. J. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00362 · Cited by 149
d ‐penicillamine reduces serum oxidative stress in Alzheimer’s disease patients
Squitti, R., Rossini, P. M., Cassetta, E., Moffa, F., Pasqualetti, P., Cortesi, M., Colloca, A., Rossi, L. C., & Finazzi‐Agrò, A. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00933.x · Cited by 145
The molecular basis of copper and iron interactions
Sharp, P. (2004) · Proceedings of The Nutrition Society · doi:10.1079/pns2004386 · Cited by 145
Golgi in copper homeostasis: a view from the membrane trafficking field
Polishchuk, R., & Lutsenko, S. (2013) · Histochemistry and Cell Biology · doi:10.1007/s00418-013-1123-8 · Cited by 144
Li, D., Zhang, W., Wang, Z., & Zhao, P. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00300 · Cited by 144
Metal ionophores – An emerging class of anticancer drugs
Ding, W., & Lind, S. E. (2009) · IUBMB Life · doi:10.1002/iub.253 · Cited by 143
Nyasae, L. K., Bustos, R., Braiterman, L., Eipper, B. A., & Hubbard, A. L. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00472.2006 · Cited by 141
Park, K. C., Fouani, L., Jansson, P. J., Wooi, D., Sahni, S., Lane, D. J. R., Palanimuthu, D., Lok, H. C., Kovačević, Ž., Huang, M., et al. (2016) · Metallomics · doi:10.1039/c6mt00105j · Cited by 141
Intestinal regulation of copper homeostasis: a developmental perspective
Lönnerdal, B. L. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.3.846s · Cited by 134
Moriya, M., Ho, Y., Grana, A., Nguyen, L., Alvarez, A., Jamil, R., Ackland, M. L., Michalczyk, A. A., Hamer, P., Ramos, D., et al. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00029.2008 · Cited by 130
Cu(II)-catalyzed oxidation of dopamine in aqueous solutions: Mechanism and kinetics
Pham, A. N., & Waite, T. D. (2014) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2014.03.018 · Cited by 129
Metal protein attenuating compounds for the treatment of Alzheimer's dementia
Sampson, E. L., Jenagaratnam, L., & McShane, R. H. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005380.pub5 · Cited by 128
Wang, Z., Wang, Y., Li, W., Mao, F., Sun, Y., Huang, L., & Li, X. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500119g · Cited by 126
Brown, L. R., & Harris, D. A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01996.x · Cited by 123
Wilson's disease: MRI with clinical correlation
Magalhães, A. C., Caramelli, P., MENEZES, J. R., Lo, L. S., Bacheschi, L. A., Barbosa, E. R., Rosemberg, L. A., & Magalhaes, A. (1994) · Neuroradiology · doi:10.1007/bf00588068 · Cited by 121
Bhattacharjee, A., Chakraborty, K., & Shukla, A. (2017) · Metallomics · doi:10.1039/c7mt00066a · Cited by 121
The Function of ATPase Copper Transporter ATP7B in Intestine
Pierson, H. E., Muchenditsi, A., Kim, B.-E., Ralle, M., Zachos, N. C., Hüster, D., & Lutsenko, S. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.09.019 · Cited by 120
Copper, Ceruloplasmin, Superoxide Dismutase and Iron Parameters in Parkinson's Disease
Tórsdóttir, G., Kristinsson, J., Sveinbjörnsdóttir, S., Snædal, J., & Jøhannesson, T. (1999) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1999.tb02015.x · Cited by 118
Wilson’s Disease: A Comprehensive Review of the Molecular Mechanisms
Wu, F., Wang, J., Pu, C., Qiao, L., & Jiang, C. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16036419 · Cited by 118
Trist, B. G., Davies, K. M., Cottam, V., Genoud, S., Ortega, R., Roudeau, S., Carmona, A., Silva, K. D., Wasinger, V. C., Lewis, S. J. G., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1726-6 · Cited by 118
NMR mapping of copper binding sites in alpha-synuclein
Sung, Y., Rospigliosi, C. C., & Eliezer, D. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.11.003 · Cited by 117
The psychiatric presentations of Wilson's disease
Akil, M., Schwartz, J. A., Dutchak, D., Yuzbasiyan‐Gurkan, V., & Brewer, G. J. (1991) · Journal of Neuropsychiatry · doi:10.1176/jnp.3.4.377 · Cited by 116
Song, I., Chen, H. H. W., Aiba, I., Hossain, A., Zheng, L., Klomp, L. W. J., & Kuo, M. T. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.046771 · Cited by 115
Anti-Oxidants in Parkinson's Disease Therapy: A Critical Point of View
Filograna, R., Beltramini, M., Bubacco, L., & Bisaglia, M. (2016) · Current Neuropharmacology · doi:10.2174/1570159x13666151030102718 · Cited by 114
Epidemiology and diagnostic testing for hemochromatosis and iron overload
Adams, P. C. (2015) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12347 · Cited by 113
Copper Promotes the Trafficking of the Amyloid Precursor Protein
Acevedo, K. M., Hung, Y. H., Dalziel, A. H., Li, Q., Laughton, K. M., Wikhe, K., Rembach, A., Roberts, B. R., Masters, C. L., Bush, A. I., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.128512 · Cited by 113
Altered microglial copper homeostasis in a mouse model of Alzheimer’s disease
Zheng, Z., White, C., Lee, J., Peterson, T. S., Bush, A. I., Sun, G. Y., Weisman, G. A., & Petris, M. J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06888.x · Cited by 111
Yu, Y., Rahmanto, Y. S., & Richardson, D. R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01526.x · Cited by 108
Stuerenburg, H. J. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050026 · Cited by 108
Acquisition of dietary copper: a role for anion transporters in intestinal apical copper uptake
Zimnicka, A. M., Ivy, K. D., & Kaplan, J. H. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00054.2010 · Cited by 107
Banci, L., Bertini, I., Cantini, F., Rosenzweig, A. C., & Yatsunyk, L. A. (2008) · Biochemistry · doi:10.1021/bi8004736 · Cited by 105
Lee, Y., Kim, H., Brahim, J. S., Rowan, J. S., Lee, G. S., & Dionne, R. A. (2006) · Pain · doi:10.1016/j.pain.2006.10.020 · Cited by 105
Trombley, P. Q., Horning, M. S., & Blakemore, L. J. (2000) · PubMed · Cited by 104
Ravia, J. J., Stephen, R. M., Ghishan, F. K., & Collins, J. F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506727200 · Cited by 103
Human Copper Transporter hCTR1 Mediates Basolateral Uptake of Copper into Enterocytes
Zimnicka, A. M., Maryon, E. B., & Kaplan, J. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702653200 · Cited by 102
Neuropsychiatric aspects of treated Wilson's disease
Svetel, M. V., Potrebić, A., Pekmezović, T., Tomić, A., Kresojević, N. D., Ješić, R., Dragašević, N., & Kostić, V. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.01.010 · Cited by 101
Bellingham, S. A., Ciccotosto, G. D., Needham, B. E., Fodero, L. R., White, A. R., Masters, C. L., Cappai, R., & Camakaris, J. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02731.x · Cited by 100
Denoyer, D., Pearson, H. B., Clatworthy, S. A. S., Smith, Z. M., Francis, P. S., Llanos, R. M., Volitakis, I., Phillips, W. A., Meggyesy, P. M., Masaldan, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9245 · Cited by 100
Dissecting copper homeostasis in diabetes mellitus
Lowe, J., Taveira‐da‐Silva, R., & Hilário‐Souza, E. (2017) · IUBMB Life · doi:10.1002/iub.1614 · Cited by 100
Lee, P., Falangola, M. F., Nixon, R. A., Duff, K., & Helpern, J. A. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20196 · Cited by 99
Kessler, H., Bayer, T. A., Bach, D., Schneider-Axmann, T., Supprian, T., Herrmann, W., Haber, M., Multhaup, G., Falkai, P., & Pajonk, F. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0080-1 · Cited by 98
Copper-dependent toxicity in SH-SY5Y neuroblastoma cells involves mitochondrial damage
Arciello, M., Rotilio, G., & Rossi, L. C. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.022 · Cited by 97
Copper metabolism of astrocytes
Dringen, R., Scheiber, I. F., & Mercer, J. F. B. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00009 · Cited by 97
Non-Alcoholic Fatty Liver Disease and Nutritional Implications: Special Focus on Copper
Antonucci, L., Porcu, C., Iannucci, G., Balsano, C., & Barbaro, B. (2017) · Nutrients · doi:10.3390/nu9101137 · Cited by 97
Andreassen, O. A., Dedeoglu, A., Friedlich, A., Ferrante, K. L., Hughes, D., Szabo, C., & Beal, M. F. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7633 · Cited by 96
Cognitive functioning in neurologically symptomatic and asymptomatic forms of Wilson's disease
Seniów, J. B., Bak, T., Gajda, J., et al. (2002) · Movement Disorders · doi:10.1002/mds.10195 · Cited by 95
Xie, J., & Wu, Z. (2017) · Neuroscience Bulletin · doi:10.1007/s12264-017-0107-4 · Cited by 95
The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer's Disease
Drew, S. C. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00317 · Cited by 95
Recent advances in (patho)physiology of astroglia
Verkhratsky, A., & Parpura, V. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.108 · Cited by 94
Therapeutic effects of CuII(atsm) in the SOD1-G37R mouse model of amyotrophic lateral sclerosis
McAllum, E. J., Lim, N. K.-H., Hickey, J. L., Paterson, B. M., Donnelly, P. S., Li, Q.-X., Liddell, J. R., Barnham, K. J., White, A. R., & Crouch, P. J. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.824000 · Cited by 89
Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease?
Bisaglia, M., Filograna, R., Beltramini, M., & Bubacco, L. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2013.12.009 · Cited by 88
Kessler, H., Pajonk, F., Meisser, P., Schneider-Axmann, T., Hoffmann, K.-H., Supprian, T., Herrmann, W., Obeid, R., Multhaup, G., Falkai, P., et al. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0485-7 · Cited by 87
Bilateral lesions of the basal ganglia and thalami (central grey matter)—pictorial review
Cauter, S. V., Severino, M., Ammendola, R. M., Berkel, B. V., Vavro, H., van den Hauwe, L., & Rumboldt, Z. (2020) · Neuroradiology · doi:10.1007/s00234-020-02511-y · Cited by 86
Donsante, A., Yi, L., Zerfas, P. M., Brinster, L., Sullivan, P., Goldstein, D. S., Prohaska, J. R., Centeno, J. A., Rushing, E. J., & Kaler, S. G. (2011) · Molecular Therapy · doi:10.1038/mt.2011.143 · Cited by 85
The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimers Disease
Vassar, R., & Cole, S. (2007) · Current Genomics · doi:10.2174/138920207783769512 · Cited by 84
Miotto, M., Rodríguez, E. E., Valiente‐Gabioud, A. A., Monserrat, V. T., Binolfi, A., Quintanar, L., Zweckstetter, M., Griesinger, C., & Fernández, C. O. (2014) · Inorganic Chemistry · doi:10.1021/ic4031377 · Cited by 81
Presynaptic effects of levodopa and their possible role in dyskinesia
Mosharov, E. V., Borgkvist, A., & Sulzer, D. (2014) · Movement Disorders · doi:10.1002/mds.26103 · Cited by 79
Goodyer, I. D., Jones, E. E., Monaco, A. P., & Francis, M. J. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.8.1473 · Cited by 79
Neuroinflammation and Copper in Alzheimer’s Disease
Choo, X. Y., Alukaidey, L., White, A. R., & Grubman, A. (2013) · International Journal of Alzheimer s Disease · doi:10.1155/2013/145345 · Cited by 78
Hao, W., Frei, B. B., Beckman, J. S., & Zhang, W. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01299.2010 · Cited by 78
Tosato, M., & Marco, V. D. (2019) · Biomolecules · doi:10.3390/biom9070269 · Cited by 78
Yu, C. H., Yang, N., Bothe, J. R., Tonelli, M., Nokhrin, S. M., Dolgova, N. V., Braiterman, L. T., Lutsenko, S., & Dmitriev, O. Y. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.811752 · Cited by 77
Watching the watcher: Regulation of p53 by mitochondria
Holley, A. K., & St Clair, D. K. (2009) · Future Oncology · doi:10.2217/14796694.5.1.117 · Cited by 75
Ryan, T. M., Roberts, B. R., McColl, G., Hare, D. J., Doble, P., Li, Q., Lind, M., Roberts, A. M., Mertens, H. D. T., Kirby, N. M., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2912-14.2015 · Cited by 74
Peptides as Potential Therapeutics for Alzheimer’s Disease
Ribarič, S. (2018) · Molecules · doi:10.3390/molecules23020283 · Cited by 74
Tokuda, E., Ono, S.-I., Ishige, K., Watanabe, S., Okawa, E., Ito, Y., & Suzuki, T. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.05.011 · Cited by 73
Triethylenetetramine Pharmacology and Its Clinical Applications
Lu, J. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0523 · Cited by 73
Gu, M., Bode, D. C., & Viles, J. H. (2018) · Scientific Reports · doi:10.1038/s41598-018-33935-5 · Cited by 68
Ajsuvakova, O. P., Tinkov, A. A., Willkommen, D., Skalnaya, A. A., Danilov, A. B., Pilipovich, A. A., Aschner, M., Skalny, A. V., Michalke, B., & Геннадиевна, С. М. (2019) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2019.126423 · Cited by 67
Wang, C.-Y., Xie, J.-W., Xu, Y., Wang, T., Cai, J.-H., Wang, X., Zhao, B.-L., An, L., & Wang, Z.-Y. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5158 · Cited by 66
Jiang, D., Zhang, L., Grant, G. P. G., Dudzik, C. G., Chen, S., Patel, S., Hao, Y., Millhauser, G. L., & Zhou, F. (2012) · Biochemistry · doi:10.1021/bi301053h · Cited by 66
Cited by
Zirngibl, M., Assinck, P., Sizov, A., Caprariello, A. V., & Plemel, J. R. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00538-8 · Cited by 270
Exposure of metal toxicity in Alzheimer’s disease: An extensive review
Islam, F., Shohag, S., Akhter, S., Islam, M. R., Sultana, S., Mitra, S., Chandran, D., Khandaker, M. U., Ashraf, G. M., Idris, A. M., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.903099 · Cited by 83
Metadata
- Authors
- Gromadzka, G., Tarnacka, B., Flaga, A., & Adamczyk, A.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-12-04
- Volume
- 21
- Issue
- 23
- Pages
- 9259
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3108197638
- Cited by
- 339
- References
- 250
- FWCI
- 15.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.